Skip to main content
. 2020 Nov 24;10:20436. doi: 10.1038/s41598-020-77374-7

Table 4.

Faecal bile acids in patients with IBS-D or bile acid diarrhoea.

BA concentration (nmol∙g−1) IBS-D BAD P values
Median IQR Median IQR
Total faecal BA 4716 (2259–6168) 9170 (7791–14,118) 0.01
Primary BA 246 (107–476) 1502 (299–7222) 0.03
CA 86 (61–266) 995 (129–3544) 0.05
CDCA 149 (48–256) 523 (184–1961) 0.04
Secondary BA 4412 (1979–5725) 7130 (3200–9626) 0.14
DCA 3661 (1234–4670) 5295 (2734–7469) 0.14
LCA 766 (675–1240) 1447 (466–2338) 0.25
UDCA 17 (9–52) 232 (27–702) 0.06
Glycoconjugates 67 (29–168) 79 (61–107) 0.81
Tauroconjugates 26 (17–59) 25 (12–95) 0.93
Sulfoconjugates 30 (13–91) 101 (73–553) 0.03
Unconjugated BA–Urso 4484 (2132–5793) 8465 (7145–11,723) 0.01
Ratio primary/secondary 0.08 (0.03–0.13) 0.19 (0.04–5.26) 0.37

BA were measured in a single stool sample from patients with IBS-D with (SeHCAT > 15%; n = 9), or BAD (SeHCAT < 15%; n = 10).

Comparisons were made by Mann–Whitney U-tests.

P values < 0.05 are shown in bold.